小米(01810.HK)漲3.5%創近八個月高 搭載新系統小米14系列開始生產
藍籌小米-W(01810.HK)發布全新操作系統,首款搭載新系統的小米14系列手機已交付工廠開始生產。該股升破8月尾所創近期高位12.88元,最高見13.04元,創近八個月高,現報12.98元,回升3.5%,成交已達4,658萬股,涉資5.88億元。
小米創辦人兼CEO雷軍欣然宣布,小米全新操作系統「小米澎湃OS」(Xiaomi HyperOS)正式版已經完成封包。搭載新系統第一款設備是小米14系列手機,已交付工廠開始生產,未來「小米澎湃OS」將逐步接替MIUI系統,標誌小米將邁向「人車家全生態」的關鍵跨越。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.